| dc.contributor.author | Sherman, M. | |
| dc.contributor.author | Hindes, R. G. | |
| dc.contributor.author | Kaymakoglu, S. | |
| dc.contributor.author | Brett-Smith, H. | |
| dc.contributor.author | Vaughan, J. | |
| dc.contributor.author | Yurdaydin, C. | |
| dc.contributor.author | Sollano, J. | |
| dc.contributor.author | Hadziyannis, S. | |
| dc.date.accessioned | 2021-03-03T19:00:34Z | |
| dc.date.available | 2021-03-03T19:00:34Z | |
| dc.identifier.citation | Yurdaydin C., Sollano J., Hadziyannis S., Kaymakoglu S., Sherman M., Brett-Smith H., Vaughan J., Hindes R. G. , "Entecavir results in continued virologic and biochemical improvement and HBeAg seroconversion through 96 weeks of treatment in lamivudine-refractory, HBeAg(+) chronic hepatitis B patients (ETV-026)", 41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, Avusturya, 26 - 30 Nisan 2006, cilt.44 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_523d5c67-ad2c-4dcc-8f7c-f32377b82d64 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/58405 | |
| dc.identifier.uri | https://doi.org/10.1016/s0168-8278(06)80081-4 | |
| dc.language.iso | eng | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Gastroenteroloji-(Hepatoloji) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
| dc.title | Entecavir results in continued virologic and biochemical improvement and HBeAg seroconversion through 96 weeks of treatment in lamivudine-refractory, HBeAg(+) chronic hepatitis B patients (ETV-026) | |
| dc.type | Bildiri | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 44 | |
| dc.contributor.firstauthorID | 131709 | |
